Chris Stamm
VP, Investor Relations and Communications
Replay available
Ironwood Pharmaceuticals, Inc. (IRWD) Q2 2026 Earnings Call
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Tom McCourt
Chief Executive Officer
Tammi Gaskins
Chief Commercial Officer
Jeff Silber
Chief Medical Officer and Head of Research and Drug Development
Ron Silver
Interim Chief Financial Officer
Jeff Ruberti
Chief Strategy Officer
Jason Butler
Investor, Citizens
Mohit Bansal
Analyst, Wells Fargo
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Ironwood Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.175 -- 00:00:04.818 Good morning, everyone. My name is Ian, and I will be your conference operator today. 00:00:04.818 -- 00:00:10.461 At this time, I would like to welcome everyone to the Ironwood Pharmaceuticals Q2 00:00:10.461 -- 00:00:15.684 2026 Investor Update Conference Call. All lines have been placed 00:00:15.684 -- 00:00:20.447 on mute to prevent any background noise. After the speaker's remarks, there will be a 00:00:20.447 -- 00:00:25.844 question and answer session. Thank you. I would like to now turn the call over to 00:00:25.844 -- 00:00:30.287 Chris Stamm, VP, Investor Relations and Communications. 00:00:30.287 -- 00:00:30.907 Please go ahead. 00:00:30.907 -- 00:00:32.468 Good 00:00:32.468 -- 00:00:37.430 morning, and thanks for joining our second quarter 2026 investor update. 00:00:37.430 -- 00:00:42.593 A press release issued this morning highlighting Q2 results can be found on our website. 00:00:42.593 -- 00:00:47.155 Today's call and accompanying slides include forward-looking statements within the meetings 00:00:47.155 -- 00:00:52.147 of the Private Securities Litigation Reform Act of 1995. 00:00:52.147 -- 00:00:57.149 Such statements involve risks and uncertainties that may cause actual results to differ 00:00:57.149 -- 00:01:01.792 materially. A discussion of these statements and risk factors is available on the current 00:01:01.792 -- 00:01:06.714 Safe Harbor Statement slide as well as under the heading Risk Factors in our Annual Report 00:01:06.714 -- 00:01:12.157 Form 10-K for the year ended December 31, 2025 and in our subsequent 00:01:12.157 -- 00:01:17.599 SEC filing. All forward-looking statements speak as of the date of this presentation 00:01:17.599 -- 00:01:21.738 and we undertake no obligation to update such statement...